Medical News

RSS

Pancreatic Cancer Action Network launches campaign to increase disease awareness

Lisa Niemi Swayze joins the Pancreatic Cancer Action Network to launch "Be a Hero in the Fight Against Pancreatic Cancer: Know it. Fight it. End it." campaign to increase awareness of the deadly disease that claimed the life of her husband, actor Patrick Swayze, one year ago.

15 Sep 2010

Burned-out medical students admit unprofessional conduct in relation to patient care

A Mayo Clinic study involving seven major medical schools shows a majority of medical students surveyed suffer from burnout and that those students were more likely to cheat or be dishonest in relation to patient care. The findings appear in this week's issue of JAMA.

15 Sep 2010

Norgen Biotek launches three novel kits for urine sampling

Norgen Biotek Corp, a privately held Canadian biotechnology company focusing principally on advancing a powerful proprietary technology for application in sample preparation for nucleic acid (DNA, RNA and microRNA) and protein purification, today announced the expansion of its basket of urine-based sample preparation products by launching 3 new urine concentration, preservation and isolation kits.

15 Sep 2010

UK HealthCare announces successful kidney transplant surgery in 16-year-old

UK HealthCare announces the revitalization of its pediatric kidney transplant program with the successful transplant surgery of 16-year-old Courtney Stroud, of Carlisle, Ky. Courtney's transplant was performed Aug. 31 at Kentucky Children's Hospital.

15 Sep 2010

Depression and distress among medical students

Medical students with moderate to severe depression more frequently endorsed several depression stigma attitudes than nondepressed students and had a higher rate of suicidal thoughts, according to a study in the September 15 issue of JAMA, a theme issue on medical education.

15 Sep 2010

Oramed Pharmaceuticals announces clinical trial results of ORMD-0801 capsule in Type I diabetics

Oramed Pharmaceuticals Inc. announced today successful results in an exploratory clinical trial testing the effectiveness of its oral insulin capsule (ORMD-0801) in Type I diabetes patients suffering from uncontrolled diabetes.

15 Sep 2010

AVANIR's AVP-923 Phase III STAR trial results published in 'Annals of Neurology' website

AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).

15 Sep 2010

SLActive chemical surfaces promote dental bone integration

Dental implants have offered a successful way to restore teeth for more than 20 years. New challenges for improving the process include shortening the time to restore functionality and meeting aesthetic demands. Altering implant surfaces to help promote bone integration is one solution. SLActive, a new chemically modified surface for titanium, the standard material of which implants are constructed, has shown positive results in this area.

15 Sep 2010

K-V secures $20 million loan from U.S. Healthcare

K-V Pharmaceutical Company announced today that it has entered into an agreement with U.S. Healthcare I, L.L.C. and U.S. Healthcare II, L.L.C. for a $20 million loan secured by assets of the Company. K-V will utilize the proceeds of the loan for working capital and general operating purposes.

15 Sep 2010

AAPCHO launches campaign to raise chronic hepatitis B awareness

The U.S. Department of Health and Human Services' Office of Minority Health, the Hepatitis B Foundation and the Association of Asian Pacific Community Health Organizations (AAPCHO) today launched a new campaign to raise awareness of the epidemic of chronic hepatitis B among Americans of Asian and Pacific Islander heritage.

15 Sep 2010

ITS commences treatment in synthetic universal influenza vaccine Phase I trial

Immune Targeting Systems (ITS) Limited, one of the leading developers of synthetic vaccines for mutating viruses, today announced the first patient has been treated in its Phase-I trial with its synthetic universal influenza vaccine (FP-01). Commencement of trials follows receipt of UK Regulatory Authority (MHRA) approval. Over the same period the company brought in £500,000 new investment from Esperante Ventures (UK).

15 Sep 2010

Sun Pharmaceutical announces expiration of Tender Offer for purchase of Taro Pharmaceutical shares

Sun Pharmaceutical Industries Ltd. today announced the expiration of the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), to purchase all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro) for $7.75 per Ordinary Share.

15 Sep 2010

USAID opens budget office, agency will assume more responsibility for its resources

USAID Administrator Rajiv Shah recently told agency staff "of the creation of the new USAID Office of Budget and Resource Management (BRM), to be led by his senior budgetary advisor Mike Casella," Foreign Policy's blog, "The Cable," reports, adding that this will "give USAID an increased role in developing and then justifying parts of its own budget going forward."

15 Sep 2010

FDA extends PDUFA date for AstraZeneca's ticagrelor NDA

AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has extended the time to complete its review of the New Drug Application (NDA) for ticagrelor (BRILINTA).

15 Sep 2010

Stanford Cancer Center to use TrueBeam radiation therapy technology for cancer patients

On Thursday, Sept. 16, the Stanford Cancer Center will become the first treatment center on the West Coast and the fifth in the world to offer cancer patients the TrueBeam, a machine that represents an exponential leap forward in the speed, power and precision of radiation therapy.

15 Sep 2010

Scientist to develop antibiotics for drug-resistant superbugs

Antibiotics can work miracles, knocking out common infections like bronchitis and tonsillitis. But according to the Center for Disease Control, each year 90,000 people in the U.S. die of drug resistant "superbugs" bacteria like Staphylococcus aureus (MRSA), a deadly form of staph infection resistant to normal antibiotics. Although hospital patients are particularly susceptible as a result of open wounds and weakened immune systems, the bacteria can infect anyone. Dr. Micha Fridman of Tel Aviv University's Department of Chemistry is now developing the next generation of antibiotics designed to overcome this kind of bacteria. And the key, he says, is in the bacteria itself.

15 Sep 2010

EHSI applauds Sen. Specter's support for Stem Cell Research Advancement Act

Emerging Healthcare Solutions, Inc. cheered Sen. Arlen Specter's (D-Penn.) statement of support for the Stem Cell Research Advancement Act on Monday.

15 Sep 2010

MVI agrees to provide fund for evaluating Inovio's malaria DNA vaccine candidate in non-human primates

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the PATH Malaria Vaccine Initiative (MVI) has agreed to provide follow-on funding to continue evaluation and development of Inovio's malaria DNA vaccine candidate in non-human primates.

15 Sep 2010

Children as young as 4 understand irony

New research findings from the Universit- de Montr-al reveals that children as young as four are able to understand and use irony. This study, published recently in the British Journal of Developmental Psychology, may impact the way parents communicate with their family.

15 Sep 2010

Senate amendments to strike health reform tax reporting provision fail

The Associated Press/Bloomberg Business: "The Senate failed Tuesday to repeal or ease an arcane tax reporting provision of the new health care law. ...Tucked into the health law is a requirement that businesses file tax forms called 1099s with the Internal Revenue Service for every vendor that sells them more than $600 in goods.

15 Sep 2010

Medical News

Pancreatic Cancer Action Network launches campaign to increase disease awareness

Burned-out medical students admit unprofessional conduct in relation to patient care

Norgen Biotek launches three novel kits for urine sampling

UK HealthCare announces successful kidney transplant surgery in 16-year-old

Depression and distress among medical students

Oramed Pharmaceuticals announces clinical trial results of ORMD-0801 capsule in Type I diabetics

AVANIR's AVP-923 Phase III STAR trial results published in 'Annals of Neurology' website

SLActive chemical surfaces promote dental bone integration

K-V secures $20 million loan from U.S. Healthcare

AAPCHO launches campaign to raise chronic hepatitis B awareness

ITS commences treatment in synthetic universal influenza vaccine Phase I trial

Sun Pharmaceutical announces expiration of Tender Offer for purchase of Taro Pharmaceutical shares

USAID opens budget office, agency will assume more responsibility for its resources

FDA extends PDUFA date for AstraZeneca's ticagrelor NDA

Stanford Cancer Center to use TrueBeam radiation therapy technology for cancer patients

Scientist to develop antibiotics for drug-resistant superbugs

EHSI applauds Sen. Specter's support for Stem Cell Research Advancement Act

MVI agrees to provide fund for evaluating Inovio's malaria DNA vaccine candidate in non-human primates

Children as young as 4 understand irony

Senate amendments to strike health reform tax reporting provision fail

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News